Laszlo, G S
Gudgeon, C J
Harrington, K H
Walter, R B
Article History
Received: 14 July 2015
Accepted: 21 July 2015
First Online: 21 August 2015
Competing interests
: RBW has received research funding from Amgen, Inc., Amphivena Therapeutics, Inc. and Seattle Genetics, Inc., and has been a consultant for Amphivena Therapeutics, Inc., AstraZeneca, Inc., Covagen AG and Pfizer, Inc. The remaining authors declare no conflict of interest.